MRI-guided muscle biopsy improves diagnostic yield in small- to medium-vessel vasculitis: a retrospective single-center study
Rheumatology International · 2025
DOI: 10.1007/s00296-025-06064-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology International, 2025. Verfasst von Soma Fukami und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Chuo-ku, Hamamatsu, Shizuoka, Japan. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Muscle, Skeletal, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Polyarteritis Nodosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
To evaluate the utility of magnetic resonance imaging (MRI)-guided muscle biopsy (MB) in diagnosing small- to medium-vessel vasculitis. We retrospectively included patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) or polyarteritis nodosa (PAN) between April 2020 and March 2025 who underwent MRI and MB. The primary outcome was the diagnostic sensitivity of MRI-guided MB for AAV and PAN. The secondary outcome was the diagnostic sensitivity for PAN alone. MB was considered positive when it demonstrated either necrotizing vasculitis or non-necrotizing vasculitis. Eighteen patients who underwent MRI and MB were included: 11 patients had AAV and 7 had PAN. The median interval between MRI and MB was 3.5 days. The mean Birmingham Vasculitis Activity Score was 13.6. Muscle pain was observed in 11 patients; however, none of the patients exhibited elevated creatine kinase levels. The sensitivity of MB for diagnosing AAV and PAN was 83.3% (15/18; 95% confidence intervals [CI] 58.6–96.4%), whereas that for PAN alone was 85.7% (6/7; 95% CI 42.1–96.3%). No biopsy-related complications were observed. There were no apparent differences in clinical characteristics between the MB-positive and MB-negative groups. MRI-guided MB may represent a diagnostic option for small- to medium-vessel vasculitis, even in patients without muscle pain or when other suitable biopsy sites are unavailable. Although this was a small exploratory retrospective single-center study, these findings should be validated in larger multicenter prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Chuo-ku, Hamamatsu, Shizuoka, Japan.
- Department of Rheumatology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Chuo-ku, Hamamatsu, Shizuoka, Japan. s-omura0018@sis.seirei.or.jp.
- Department of Radiology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Chuo-ku, Hamamatsu, Shizuoka, Japan.
- Department of Pathology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Chuo-ku, Hamamatsu, Shizuoka, Japan.
- Division of Immunology and Rheumatology, Third Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu, Shizuoka, Japan.
Zitieren
APA
Fukami, S., Ohmura, S. I., Masui, T., Otsuki, Y., Yukishima, T., Yonezawa, H., Ohkubo, Y., Miyamoto, T., & Shimoyama, K. (2025). MRI-guided muscle biopsy improves diagnostic yield in small- to medium-vessel vasculitis: a retrospective single-center study. Rheumatology International. https://doi.org/10.1007/s00296-025-06064-2
Vancouver
Fukami S, Ohmura SI, Masui T, Otsuki Y, Yukishima T, Yonezawa H, et al. MRI-guided muscle biopsy improves diagnostic yield in small- to medium-vessel vasculitis: a retrospective single-center study. Rheumatology International. 2025. doi:10.1007/s00296-025-06064-2
BibTeX
@article{Fukami2025,
author = {Fukami, Soma and Ohmura, Shin-Ichiro and Masui, Takayuki and Otsuki, Yoshiro and Yukishima, Toshitaka and Yonezawa, Haruka and Ohkubo, Yusuke and Miyamoto, Toshiaki and Shimoyama, Kumiko},
title = {MRI-guided muscle biopsy improves diagnostic yield in small- to medium-vessel vasculitis: a retrospective single-center study},
journal = {Rheumatology International},
year = {2025},
doi = {10.1007/s00296-025-06064-2}
}
EUVIMED